checkAd
    Startseite > Aktien > Aditxt > Nachrichten
    Aditxt Aktie
    2,0700
     
    USD
    -0,48 %
    -0,0100 USD
    Letzter Kurs 02:00:00 Nasdaq
    2,0700
     
    USD
    2.400 STK
    Geldkurs 09.05.24
    2,1000
     
    USD
    600 STK
    Briefkurs 09.05.24
    ISIN: US0070256047 · WKN: A3ETCJ · SYM: ADTX · USA

    Neueste Nachrichten

    Aditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq Rules
    03.05.24 · Business Wire (engl.) · Aditxt
    Aditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD)
    02.04.24 · Business Wire (engl.) · Appili Therapeutics Registered (A)
    Aditxt, Inc. Acquires Proprietary Electroencephalography (EEG) Brain Monitoring Technologies and Devices, Including NeuroCap and NeuroEEG for Telehealth and Tele-neurology Applications
    30.01.24 · Business Wire (engl.) · Aditxt
    Aditxt, Inc.’s Subsidiary Pearsanta, Inc. Acquires MDNA Life Sciences Inc.’s Proprietary Mitomic Testing Platform Pioneering Early Disease and Cancer Detection in a Transaction Valued at Approximately $25 Million
    08.01.24 · Business Wire (engl.) · Aditxt
    Aditxt Announces Closing of $6.0 Million Private Placement Priced At-The-Market under Nasdaq Rules
    05.01.24 · Business Wire (engl.) · Aditxt
    Aditxt, Inc. Regains Compliance with Nasdaq Stockholders’ Equity Requirement
    02.01.24 · Business Wire (engl.) · Aditxt
    Aditxt Announces $6 Million Private Placement Priced At-The-Market under Nasdaq Rules
    29.12.23 · Business Wire (engl.) · Aditxt
    ADTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aditxt, Inc. Is Fair to Shareholders
    12.12.23 · Business Wire (engl.) · Aditxt
    Aditxt, Inc. Enters into Definitive Agreement to Acquire Evofem Biosciences, Inc., Creator of Phexxi, the First and Only FDA-Approved Hormone-Free Contraceptive Gel, to Address Diverse Reproductive Health Needs of Women Globally
    12.12.23 · Business Wire (engl.) · Evofem Biosciences
    Aditxt, Inc. to Present at 8th Annual Dawson James Conference
    06.10.23 · globenewswire · Aditxt
    Aditxt, Inc. Announces Appointment of Ernie Lee as CEO of its Wholly-Owned Subsidiary, Pearsanta, to Lead Launch of Test2Treat.me Platform
    05.10.23 · Business Wire (engl.) · Aditxt
    Aditxt, Inc. (NASDAQ: ADTX) Announces Participation at the H.C. Wainwright 25th Annual Global Investment Conference September 11th-13th, 2023
    08.09.23 · Business Wire (engl.) · Aditxt